Modeling the hepatitis C virus epidemic in France

Hepatology

Volumn 29, Issue 5, 1999, Pages 1596-1601

  Deuffic, Sylvie ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CHRONICITY; DISEASE ACTIVITY; DISEASE COURSE; EPIDEMIC; FRANCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MORTALITY; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGE DISTRIBUTION; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE OUTBREAKS; DISEASE PROGRESSION; FEMALE; FORECASTING; FRANCE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PROBABILITY; SEX DISTRIBUTION; TIME FACTORS;

EID: 0032899160     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290528     Document Type: Article

References (4)

1. Dubois F, Desenclos JC, Mariotte N, Goudeau A, and the Collaborative Study Group. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. HEPATOLOGY 1997;25:1490-1496.
2. Poynard T, Bedossa P, Opolon P, for the OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-832.
3. Darby SC, Ewart DW, Giangrande PLF, Spooner RJD, Rizza CR, Dusheiko GM, Lee CA, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet 1997;350:1425-1431.
4. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, Hollinger FB, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992;327:1906-1911.